STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION  
For procedures finalised after 1 September 2004 please refer to module 8B. 
Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below: 
Scope 
Application 
number 
Type of 
modification1 
Change in pack size for a medicinal product. 
 Change in the name of a manufacturer of the medicinal product. 
 Change of manufacturing site for part or all of the manufacturing 
process of the medicinal product. 
The change relates to the transfer of local representatives for Nordic 
countries (Finland, Sweden, Denmark, Norway and Island) to 
Belgium (Bruxelles) mentioned in the Package Leaflet text (Annex 
IIIB) in all language version. 
The marketing authorisation holder applied to introduce a new 1-vial 
pack of the HBVAXPRO 5µg/0.5ml, which includes an empty 
syringe with needle. The marketing authorisation holder took the 
opportunity of this variation to update the list of local representatives 
in the package leaflet and to introduce  the product information for 
the new EU member states. 
Change(s) to the test method(s) and/or specifications for the active 
substanceChange(s) to the test method(s) and/or specifications for 
the finished product 
Notification/ 
Opinion 
issued on2 
30.08.01 
22.11.01 
30.11.01 
23.10.02 
Commission 
Decision 
Issued/amen
ded on 
15.11.01 
- 
- 
- 
I/0001 
I/0003 
I/0002 
N/0004 
I 
I 
I 
N 
IA/006 
IA 
05/07/04 
II/0005 
II 
29/07/04 
03/08/04 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers 
to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a 
minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an 
Annex II application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) 
No 2141/96 of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 
March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification 
date. The Commission Decision will be amended accordingly. 
1/1 
EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      
 
